NAGE stock

Niagen Bioscience, Inc. (NAGE) financials · rev $129.4M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Niagen Bioscience, Inc. (NAGE) rev $129.4M.

Cached annual income statement
LineFY2025FY2024
Revenue$129.4M$99.6M
Cost of Revenue$46.2M$38.0M
Gross Profit$83.2M$61.6M
Operating Income$16.3M$7.73M
Net Income$17.4M$8.55M
EPS (Diluted)$0.20$0.11
Cached annual balance sheet
LineFY2025FY2024
Total Assets$106.4M$68.3M
Current Assets$96.8M$64.1M
Cash & EquivalentsN/A$44.5M
Inventory$20.4M$9.19M
Total Liabilities$29.9M$22.2M
Current Liabilities$19.9M$17.9M
Shareholders' Equity$76.5M$46.1M
Retained Earnings-$164.5M-$181.9M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow$13.5M$12.1M
Investing Cash Flow-$292.0K-$143.0K
Financing Cash Flow$6.92M$5.37M
Net Change in Cash$20.1M$17.3M
These statements as JSON? API free 100/day

FAQ

What is NAGE P/E and revenue?

Niagen Bioscience, Inc. (NAGE) rev $129.4M.

What is NAGE revenue?

Niagen Bioscience, Inc. last cached revenue is $129.4M (FY2025).

Is NAGE profitable?

Niagen Bioscience, Inc. last cached net income is $17.4M (FY2025).

What are NAGE total assets?

Niagen Bioscience, Inc. last cached total assets are $106.4M (FY2025).

What is NAGE free cash flow?

No cached cash-flow row for NAGE yet.

Not investment advice. Cached statements, not a live tape.